Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC.SI · Entity 5607 | Director · Chief Operating Officer | August 14, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SHOULDER INNOVATIONS, INC.
Report date August 14, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 244,176 |
Ending reported balance
After 2026-08-18 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-08-14 · Gift · Disposed 2,500 · Balance 266,676 Row 2 · 2026-08-17 · Sale · Disposed 8,314 · Balance 258,362 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026. F2: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $20.00 to $20.525, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Row 3 · 2026-08-18 · Sale · Disposed 12,586 · Balance 245,776 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026. F3: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $20.25 to $21.24, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Row 4 · 2026-08-18 · Sale · Disposed 1,600 · Balance 244,176 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026. F4: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $21.25 to $21.46, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.
F2: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $20.00 to $20.525, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F3: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $20.25 to $21.24, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F4: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $21.25 to $21.46, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 18, 2026 Filed Aug 18, 2026 20:47 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | SaleCommon Stock | 1,600 | $21.38 | $34,211.04 |
DisclosureSEC source: 0002070582-26-000005 · wk-form4_1787086042.xml · nonDerivative · entry 4 Ahearn Matthew Fraser · CIK 0002070582 · Director · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 244,176 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026. F4 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $21.25 to $21.46, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| August 18, 2026 Filed Aug 18, 2026 20:47 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | SaleCommon Stock | 12,586 | $20.94 | $263,492.94 |
DisclosureSEC source: 0002070582-26-000005 · wk-form4_1787086042.xml · nonDerivative · entry 3 Ahearn Matthew Fraser · CIK 0002070582 · Director · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 245,776 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026. F3 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $20.25 to $21.24, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 20:47 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | SaleCommon Stock | 8,314 | $20.10 | $167,101.42 |
DisclosureSEC source: 0002070582-26-000005 · wk-form4_1787086042.xml · nonDerivative · entry 2 Ahearn Matthew Fraser · CIK 0002070582 · Director · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 258,362 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026. F2 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $20.00 to $20.525, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:47 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0002070582-26-000005 · wk-form4_1787086042.xml · nonDerivative · entry 1 Ahearn Matthew Fraser · CIK 0002070582 · Director · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 266,676 Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:35 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | SaleCommon Stock | 2,500 | $19.26 | $48,148.00 |
DisclosureSEC source: 0002070582-26-000004 · wk-form4_1781642097.xml · nonDerivative · entry 3 Ahearn Matthew Fraser · CIK 0002070582 · Director · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 269,176 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026. F5 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $18.98 to $19.71, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:35 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | SaleCommon Stock | 1,644 | $18.20 | $29,921.62 |
DisclosureSEC source: 0002070582-26-000004 · wk-form4_1781642097.xml · nonDerivative · entry 2 Ahearn Matthew Fraser · CIK 0002070582 · Director · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 271,676 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026. F4 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $17.98 to $18.88, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 20:35 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | SaleCommon Stock | 15,856 | $18.68 | $296,185.32 |
DisclosureSEC source: 0002070582-26-000004 · wk-form4_1781642097.xml · nonDerivative · entry 1 Ahearn Matthew Fraser · CIK 0002070582 · Director · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 273,320 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026. F2 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $18.29 to $19.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F3 · balance_after: Includes the following shares received without consideration as an in-kind distribution: 2,411 shares from Genesis Investment Holdings. In prior reports, the reporting person reported beneficial ownership of 286,765 shares of Shoulder Innovations common stock held directly. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:39 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionStock Option · Derivative | 14,243 | $0.00 Strike: $2.86 | $0.00 |
DisclosureSEC source: 0002070582-26-000003 · wk-form4_1776803956.xml · derivative · entry 4 Ahearn Matthew Fraser · CIK 0002070582 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,731 Underlying: Common Stock · 14,243 shares Expires 2035-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vested as to one-fourth of the underlying shares on April 1, 2026, and the remaining shares vest in 12 equal increments on the last day of each fiscal quarter beginning on June 30, 2026. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:39 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionStock Option · Derivative | 7,421 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0002070582-26-000003 · wk-form4_1776803956.xml · derivative · entry 3 Ahearn Matthew Fraser · CIK 0002070582 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,864 Underlying: Common Stock · 7,421 shares Expires 2033-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vested as to one-fourth of the underlying shares on April 19, 2024, and the remaining shares vest in 36 equal increments on the last day of each calendar month thereafter. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:39 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionCommon Stock | 14,243 | $2.86 | $40,763.47 |
DisclosureSEC source: 0002070582-26-000003 · wk-form4_1776803956.xml · nonDerivative · entry 2 Ahearn Matthew Fraser · CIK 0002070582 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:39 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionCommon Stock | 7,421 | $2.48 | $18,407.05 |
DisclosureSEC source: 0002070582-26-000003 · wk-form4_1776803956.xml · nonDerivative · entry 1 Ahearn Matthew Fraser · CIK 0002070582 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes the following shares received without consideration as in-kind distributions: (i) 39,404 shares from Genesis Investment Holdings; (ii) 1,572 shares from cultivate(MD) Capital Accelerator Fund, L.P.; (iii) 4,400 shares from Cultivate MD Capital Fund I, LLC; and (iv) 3,869 shares from Cultivate MD Capital Fund II, LP. In prior reports, the reporting person reported beneficial ownership of 215,856 shares of Shoulder Innovations common stock held directly. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:31 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | GrantStock Option · Derivative | 88,450 | $0.00 Strike: $14.16 | $0.00 |
DisclosureSEC source: 0002070582-26-000002 · wk-form4_1770154283.xml · derivative · entry 1 Ahearn Matthew Fraser · CIK 0002070582 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,450 Underlying: Common Stock · 88,450 shares Expires 2033-01-30 F1 · derivative.exercise_date: The stock option vests as to one-fourth of the underlying shares on March 1st each year, beginning on March 1, 2027. Read SEC document |
| December 31, 2025 Filed Jan 8, 2026 21:52 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | GrantCommon Stock | 477 | $12.16 | $5,800.32 |
DisclosureSEC source: 0002070582-26-000001 · wk-form4_1767909157.xml · nonDerivative · entry 1 Ahearn Matthew Fraser · CIK 0002070582 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,856 F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2025 Employee Stock Purchase Plan ("ESPP") . F2 · price: In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 31, 2025. Read SEC document |
| September 11, 2025 Filed Sep 15, 2025 20:09 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionStock Option · Derivative | 16,443 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001493152-25-013467 · ownership.xml · derivative · entry 6 Ahearn Matthew Fraser · CIK 0002070582 · Director · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,285 Underlying: Common Stock · 16,443 shares Expires 2033-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vested as to one-fourth of the underlying shares on April 19, 2024, and the remaining shares vest in 36 equal increments on the last day of each calendar month thereafter. Read SEC document |
| September 11, 2025 Filed Sep 15, 2025 20:09 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionStock Option · Derivative | 78,616 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001493152-25-013467 · ownership.xml · derivative · entry 5 Ahearn Matthew Fraser · CIK 0002070582 · Director · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 78,616 shares Expires 2030-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| September 11, 2025 Filed Sep 15, 2025 20:09 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionStock Option · Derivative | 12,286 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001493152-25-013467 · ownership.xml · derivative · entry 4 Ahearn Matthew Fraser · CIK 0002070582 · Director · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,286 shares Expires 2027-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| September 11, 2025 Filed Sep 15, 2025 20:09 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionCommon Stock | 16,443 | $2.48 | $40,785.22 |
DisclosureSEC source: 0001493152-25-013467 · ownership.xml · nonDerivative · entry 3 Ahearn Matthew Fraser · CIK 0002070582 · Director · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,379 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2025 Filed Sep 15, 2025 20:09 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionCommon Stock | 78,616 | $2.10 | $164,999.26 |
DisclosureSEC source: 0001493152-25-013467 · ownership.xml · nonDerivative · entry 2 Ahearn Matthew Fraser · CIK 0002070582 · Director · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2025 Filed Sep 15, 2025 20:09 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionCommon Stock | 12,286 | $0.93 | $11,486.18 |
DisclosureSEC source: 0001493152-25-013467 · ownership.xml · nonDerivative · entry 1 Ahearn Matthew Fraser · CIK 0002070582 · Director · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:05 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | ConversionSeries B Convertible Preferred Stock · Derivative | 218,217 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001641172-25-022248 · ownership.xml · derivative · entry 4 Ahearn Matthew Fraser · CIK 0002070582 · Director · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,436 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:05 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | ConversionSeries A Convertible Preferred Stock · Derivative | 814,093 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001641172-25-022248 · ownership.xml · derivative · entry 3 Ahearn Matthew Fraser · CIK 0002070582 · Director · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:05 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | ConversionSeries Seed Convertible Preferred Stock · Derivative | 250,710 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001641172-25-022248 · ownership.xml · derivative · entry 2 Ahearn Matthew Fraser · CIK 0002070582 · Director · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,139 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:05 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | ConversionCommon Stock | 67,242 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001641172-25-022248 · ownership.xml · nonDerivative · entry 1 Ahearn Matthew Fraser · CIK 0002070582 · Director · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.